Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
COX6B1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ORC1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CCHCR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
TP53I11 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FTL - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CTSO - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
BOLA2B - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RPN2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
HAUS5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RBM14-RBM4 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IKBKE - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
VWA5A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
POLR2K - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PFDN5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ARL14 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
RHBDD3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GBP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IFNGR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
NABP1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
B2M - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on